Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer

  • Saman Farahmand
  • , Aileen I. Fernandez
  • , Fahad Shabbir Ahmed
  • , David L. Rimm
  • , Jeffrey H. Chuang
  • , Emily Reisenbichler
  • , Kourosh Zarringhalam

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)44-51
Number of pages8
JournalModern Pathology
Volume35
Issue number1
DOIs
StatePublished - Jan 2022

ASJC Scopus Subject Areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer'. Together they form a unique fingerprint.

Cite this